Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2007
10/17/2007CN100342911C Bivalent DNA vaccine of type A and type O foot-and-mouth disease virus and its preparing process
10/16/2007US7282578 Having at least one intron sequence; constructs and host cells; expression product and antibodies obtainable by immunization of an animal therewith, as well as the use of antibodies in screening methods for the identification of tumors
10/16/2007US7282564 RNA interference pathway genes as tools for targeted genetic interference
10/16/2007US7282490 Osteopontin-related compositions and methods
10/16/2007US7282489 Delivering plasmid vector encoding HERG (A561V) (human ether-a-go-go related gene) protein to cells afflicted with re-entrant atrial flutter mediated cardiac arrhythmia
10/16/2007US7282488 Introducing a nucleic acid encoding an agent that increases activated protein C; expressing the agent in the cells; and increasing the APC sufficient to treat the blood vessel.
10/16/2007US7282476 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
10/16/2007US7282364 Expression cassette generated from these sequences; generating an immune response in a subject
10/16/2007US7282341 Method for early detection during the clinical phase of the infection, reliable, rapid, inexpensive, making it possible to adapt the medical care in time
10/16/2007US7282200 Composition of fibroblast or chondrocyte cells transfected or transduced with a gene encoding transforming growth factor beta 1 (TGF- beta 1) or bone morphogenetic protein 2 (BMP-2), and chondrocyte cells that have not been transfected with the gene; generating hyaline cartilage at a target site
10/16/2007US7282199 Genetic engineered polypeptide; inserted into cell; blood disorders
10/16/2007US7282198 Immunotherapeutic methods targeted towards stratum corneum chymotryptic enzyme
10/11/2007WO2007115175A2 Cyclic natriuretic peptide constructs
10/11/2007WO2007115155A2 Method of making a multilayered duplex material article
10/11/2007WO2007115066A2 Facilitating application synchronization with a reservation protocol at a sender without application receiver participation
10/11/2007WO2007114762A1 Method of separation of deoxyribonucleic acids
10/11/2007WO2007114239A1 ANTI-CANCER AGENT COMPRISING DGKα INHIBITOR
10/11/2007WO2004056979A3 Recombinant virus production for the manufacturing of vaccines
10/11/2007US20070238693 Genetic modification of the lung as a portal for gene delivery
10/11/2007US20070238692 Compositions and methods for treating diseases associated with T-Box and N-Myc
10/11/2007US20070238691 Inhibition of HIV replication and expression of p24 with eIF-5A
10/11/2007US20070238690 Modulation of glucagon receptor expression
10/11/2007US20070238689 Modulation of glucagon receptor expression
10/11/2007US20070238688 Modulation of glucagon receptor expression
10/11/2007US20070238687 Modulation of glucagon receptor expression
10/11/2007US20070238686 Inhibition of Chronic Myelogenous Leukemic Cell Growth By Liposomal-Antisense Oligodeoxy-Nucleotides Targeting To Grb2 or Crk1
10/11/2007US20070238684 For an improved in vitro and in vivo transformation of particular cells, for example for somatic gene therapy; diagnosis, increased infectivity for cells of low susceptibility, such as haematopoietic cells
10/11/2007US20070238683 Modified and stabilized gdf propeptides and uses thereof
10/11/2007US20070238680 Substance and process for preventing a genetic defect from being passed onto offspring
10/11/2007US20070238678 Methods and compositions for inhibition of innate immune responses and autoimmunity
10/11/2007US20070238677 Pharmaceutical Composition Containing Hshrd3
10/11/2007US20070238675 Stem Cell Beacon
10/11/2007US20070238666 Cancer treatment by administration of a synthetic peptide comprising a sequence of amino acids within the p53 protein and a membrane penetrating leader sequence
10/11/2007US20070238658 IL-17A and IL-17F Antagonists and Methods of Using the Same
10/11/2007US20070238651 Nucleic acids and proteins of a rat ganglioside GM1-specific alpha1-2fucosyltransferase and uses thereof
10/11/2007US20070238649 Agents for Regulating Adiponectin Receptor Expression
10/11/2007US20070238647 Administering physiological agent that decreases or regulates blood or tissue levels, expression, production, function, or activity of luteinizing hormone (LH), LH receptors, follicle stimulating hormone (FSH), FSH receptor, androgenic steroid, androgenicsteroid receptors, an activin, activin receptor
10/11/2007US20070238644 Human Chemokines CKBeta-4 and CKBeta-10/MCP-4
10/11/2007US20070238178 Cancer vaccines; infections from Retrovirus, Herpesvirus, Hepadenovirus, Poxvirus, Parvovirus, Papillomavirus, or Papovavirus; reduced side effects; a hairpin RNA having a double stranded region of between 11 to 30 nucleotides; gene expression inhibition
10/11/2007US20070238119 Method for detecting cancer and method for suppressing cancer
10/11/2007US20070238086 Identification of oligonucleotides for the capture, detection and quantitation of West Nile virus
10/11/2007US20070237781 Biologically active metal-containing nucleic acids
10/11/2007US20070237778 Using bone morphogenic protein specific immunoglobulin for treatment and prevention of osteopenia, osteomalacia, osteoporosis, osteomyeloma, osteodystrophy and paget's disease
10/11/2007US20070237777 Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
10/11/2007US20070237754 Transient immortalization
10/11/2007US20070237753 Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene
10/11/2007US20070237746 administering combination of extract of Vitreoscilla filiformis bacteria and lycopene as antioxidant for limiting and/or eliminating objectionable body odors caused by skin lipid oxidation; catalase or peroxidase activity
10/11/2007US20070237745 SISP-1 (Stress induced Secreted Protein 1); induces apoptosis by interaction with p53; treating abnormal apoptosis such as tumor
10/11/2007US20070237744 Targeted Gene Delivery to Non-Phagocytic Mammalian Cells Via Bacterially Derived Intact Minicells
10/11/2007US20070237722 Neural conduit agent dissemination
10/11/2007DE102006016365A1 Composition for inhibiting expression of one or more target genes in a eukaryotic cell comprises one or more genetic constructs comprising a target gene and a small interfering RNA tag
10/11/2007DE10158523B4 Hemmung der Transkription eines Zielgens in einer Zelle oder in Geweben Inhibition of transcription of a target gene in a cell or in tissue
10/10/2007EP1842921A1 Recombined adenovirus p53 preparation for treating tumor
10/10/2007EP1842919A1 DNA sequences having anti-repressor activity
10/10/2007EP1842918A1 Receptor nucleic acids and polypeptides
10/10/2007EP1842917A1 Sequences of an Ih ion channel and their application
10/10/2007EP1842856A2 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
10/10/2007EP1842552A1 Treatment for diabetes
10/10/2007EP1841878A1 Method for the generation of virus producing cell lines and cell lines
10/10/2007EP1841868A2 Inhibitor nucleic acids
10/10/2007EP1841789A2 Hiv resistance genes
10/10/2007EP1841463A2 Methods and compositions for treating, inhibiting and reversing disorders of the intervertebral disc
10/10/2007EP1841462A2 Growth factor therapy mobilization of stem cells into the peripheral blood
10/10/2007EP1841461A1 Injectable agent for the targeted treatment of retinal ganglion cells
10/10/2007EP1511509B1 Compositions and methods for treating diabetes
10/10/2007EP1181304B1 Antiproliferative activity of g-righ oligonucleotides and method of using same to bind to nucleolin
10/10/2007EP1177301B1 Chlamydia antigens and corresponding dna fragments and uses thereof
10/10/2007EP1090924B1 Tumor antigen peptides originating in cyclophilin b
10/10/2007EP0669973B9 Biological factors and neural stem cells
10/10/2007CN101052718A Mutated amyloid protein
10/10/2007CN101052717A Polynucleotide causing RNA interfere and method of regulating gene expression with the use of the same
10/10/2007CN101052644A RNAi therapeutics for treatment of eye neovascularization diseases
10/10/2007CN101052422A Compositions and methods for protein production
10/10/2007CN101052421A Phospholipase enzymes c-ªå regulating and its application for controlling pain and injury effect
10/10/2007CN101052415A Methods and compositions for treating and preventing inflammatory conditions
10/10/2007CN101052305A Isolated lineage negative hematopoietic stem cells and methods of treatment therewith
10/10/2007CN101050448A Oral recombined DNA vaccine for accelerating growth of animal, and application
10/10/2007CN101049508A Carrier bacterin of attenuated typhoid bacterium of carrying tubercle branch bacillus Ag85B
10/10/2007CN101049507A Pitx3 gene and application of promoter
10/10/2007CN101049506A DNA preparation of virus M protein of bubble stomatitis, preparation method and application
10/10/2007CN100342017C Gene recombined chemotaxis antigen vaccine
10/10/2007CN100341579C Method for preparing gene therapeutic tissue engineering stent
10/10/2007CN100341572C Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26
10/09/2007US7279568 Highly efficient eukaryotic expression vector comprising an exogenous transcription regulatory element
10/09/2007US7279567 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response
10/09/2007US7279555 Derived from duck hepatitis B virus core protein; haptens; gene therapy
10/09/2007US7279464 For immunizing a mammal against cancer cells that present a carcinoembryonic antigen (CEA)
10/09/2007US7279462 Administering to a lymphoid tissue in vivo a plasmid vector containing a nucleic acid molecule comprising a B cell specific expression element operationally linked to a nucleic acid sequence encoding one or more heterologous epitopes
10/09/2007US7279334 Increasing recombination between homologous chromosomes in a dividing cell by introducing a nucleic acid sequence encoding a fusion protein having a DNA binding domain that recognizes a DNA sequence in the chromosomes linked to a Spo11 protein, and having the cell divide
10/09/2007US7279333 Virus envelope vector for gene transfer
10/09/2007US7279331 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders
10/09/2007US7279326 composition for delivering a wild-type mitochondrial DNA molecule to a mammalian cell, comprising: a wild-type mammalian mitochondrial DNA molecule having a mitochondrial leader sequence peptide attached to facilitate uptake into the cell; gene therapy of conditions caused by mitochondrial DNA defect
10/09/2007US7279322 Electrospraying apparatus and method for coating particles
10/09/2007US7279318 Reacting the elements such as viruses and other micro-organisms with a synthetic hydrophilic multivalent polymer with a backbone based upon monomer units of N-2-hydroxypropylmethacrylamide, N-(2-Hydroxy ethyl)-L-Glutamine, ethyleneglycol-oligopeptide or dextran monomers and multiple reactive groups
10/09/2007US7279313 Circular DNA molecule having a conditional origin of replication, process for their preparation and their use in gene therapy
10/09/2007US7279305 Gene, disrupted in schizophrenia
10/09/2007US7279181 Spraying the stabilized solution across a pressure drop in into an expansion vessel to cause the supercritical fluid or compressed gas to decompress into a gas phase and to cause the discontinuous phase to freeze; and freeze-drying to form particles devoid of solvents and the supercritical fluid or gas
10/09/2007US7279166 Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
10/09/2007CA2294579C Liposome-entrapped polynucleotide composition and method
10/09/2007CA2253393C Dispersible macromolecule compositions and methods for their preparation and use
1 ... 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 ... 870